Related Experiment Videos
HLA in hypertrophic cardiomyopathy and rheumatic heart disease
Insights
Human Leukocyte Antigen (HLA) associations suggest a role in familial hypertrophic cardiomyopathy. While not statistically significant in all cases, specific HLA antigens were linked to disease occurrence in affected families.
Area of Science:
- Immunogenetics
- Cardiology
- Human Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition with a significant familial component.
- The role of genetic factors, particularly the Human Leukocyte Antigen (HLA) system, in HCM pathogenesis remains an area of investigation.
Purpose of the Study:
- To investigate potential associations between specific HLA antigens and the occurrence of hypertrophic cardiomyopathy in a Japanese cohort.
- To explore the correlation between HLA antigen inheritance and familial aggregation of HCM.
Main Methods:
- HLA antigen typing was performed on 30 Japanese patients diagnosed with hypertrophic cardiomyopathy.
- Family studies were conducted to analyze HLA antigen inheritance patterns in affected kindreds.
- HLA antigen frequencies in HCM patients were compared to control groups.
Main Results:
- While several HLA antigens showed higher frequencies in HCM patients compared to controls, these differences did not reach statistical significance.
- In familial cases, inheritance of HLA-A9 and HLA-B7 was observed in a majority of affected individuals, and absence of HLA-B7 was associated with no disease manifestation.
- Specific HLA antigens, HLA-A2 and HLA-BW35, were noted in affected members of other families.
- No significant differences in HLA antigen frequencies were found between patients with rheumatic valvular heart disease and controls.
Conclusions:
- The study suggests a potential role for the HLA system in the pathogenesis of familial hypertrophic cardiomyopathy.
- Further research is warranted to elucidate the specific mechanisms linking HLA genetics to HCM development.
Abstract:
1. HLA antigens were determined in 30 Japanese patients with hypertrophic cardiomyopathy. Several antigens were more common in patients compared with controls, but statistically significant differences were not evidenced. In families one and two, six of seven kindred who inherited HLA-A9 and B7 had the disease. None of five kindred lacking HLA-B7 showed evidence of the disease. In families three and four, affecting family members had HLA-A2 and BW-35. Our finding suggest that the HLA system may play some role in the pathogenesis of hypertrophic cardiomyopathy with familial occurrence. 2. Twenty patients with rheumatic valvular heart disease were also studied. There was no significant difference in frequencies of HLA antigens between patients and controls.